Report Store Get Proposal

Home Blog Notizia 36

Notizia - Recent Pharma, Healthcare and Biotech Happenings

pharma-happenings-for-roche-allstripes-datavant-bluewillow-shape-therapeutics

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Shape Therapeutics-Roche’s Deal; AllStripes Raises $50M; Datavant-Real Chemistry’s Partnership; BlueWillow’s Nasal Vaccine

Shape Therapeutics inks gene therapy deal with Roche worth up to USD 3 Billion Seattle biotech firm Shape Therapeutics has signed a deal potentially exceeding USD 3 billion with pharma giant Roche to bolster the development of gene therapies for Alzheimer’s and Parkinson’s disease. Shape’s RNA editing technologies can modify the RNA sequence, which makes the body’s protein building blocks. The company will utilize this technology with Roche in preclinical studies against targets pertinent for these neurological conditions and certain rare diseases. The collaboration may also utilize the biotech company’s technologies for gene delivery. This system is designed...

Explore More...

mRNA

Biogen buys Nightstar; Pacira acquires Myoscience; Horizon Pharma announces pricing; STAT with Slingshot Insights; Epizyme announces Equity Offering

common cold

ColdZyme inactivates viruses; Med for rare genetic disease; Common oral bacteria accelerate Colon cancer; CEPI and CureVac to develop an mRNA vaccine; Celastrol’s effectiveness

The Business Cocktail

CRISPR

Notizia

Peloton Therapeutics

Peloton raises $150M; BiomX raises $32M; Abbott and Novo collaborate; Blaze Bioscience nets $5M

Kidney Cancer

Notizia

Peloton Therapeutics

Neurogene raises $68.5M; AbbVie and Teneobio sign deal; 5AM Ventures nets

Johnson & Johnson

Antidepressant of J&J leads to FDA; SCLC model discloses; Genes and macular degeneration can disclose new treatment ways

Genentech remunerates Xencor; XPrize upraises fund; GSK gambles

Kidney Cancer

Notizia

parkinson's

Voyager clears Neurocrine deal; Anthem speeds up launch; Lilly rushed its deal

Johnson & Johnson

Biodesix collaborates with MRM; Avoiding flu with an antibody; Soliris clears trial

merck

BridgeBio bags $299M; Immunochina receives $20M; Attune raises; Wren receives $23M

Oncology

Notizia

Juvenescence

Juvenescence raises $46M; Brainsway files for IPO; Life Biosciences raises

patent ductus arteriosus

Notizia

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly